<h1>CCI Approves Goldman Sachs' Investment in API Holdings, Boosting India's Healthcare Sector Expansion.</h1> The Competition Commission of India has approved the subscription of compulsorily convertible preference shares in API Holdings Limited by two schemes launched by Goldman Sachs India Alternative Investment Trust. These schemes, Acquirer 1 and Acquirer 2, are managed by Goldman Sachs (India) Alternative Investment Management Private Limited. API Holdings, the ultimate parent entity of its group, operates in the healthcare sector in India, dealing in pharmaceuticals, medical devices, OTC products, diagnostic services, and tele-medical consultations. A detailed order from the CCI regarding this transaction will be issued subsequently.